NASDAQ:BMRN

Biomarin Pharmaceutical Stock News

etoro logo Buy BMRN
*Your capital is at risk
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026

2 Best Biotech Stocks to Buy Right Now

02:35pm, Monday, 01'st Jun 2020
Revenue is climbing at these biotech companies. And one of them is waiting for what could be an historic product approval.

2 Best Biotech Stocks to Buy Right Now

10:35am, Monday, 01'st Jun 2020
Revenue is climbing at these biotech companies. And one of them is waiting for what could be an historic product approval.
Global biotech BioMarin Pharmaceutical Inc. (BMRN) has announced updated results of an open-label Phase 1/2 study of valoctocogene roxaparvovec, an investigational gene therapy treatment for adults wi
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today an update to its previously reported results of an open-label Phase 1/2 study of valoctocogene roxaparvovec, an investigational gene therapy
SAN RAFAEL, Calif., May 31, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today an update to its previously reported results of an open-label Phase 1/2 study of valoctocog
REGN vs. BMRN: Which Stock Is the Better Value Option?
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?
Hardening of positions comes after international outcry over China’s parliament voting to proceed with controversial national security laws
In this article we will take a look at whether hedge funds think BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a good investment right now. We check hedge fund and billionaire investor sentiment befor
All the banks and brokerage firms that we follow here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks.
SAN RAFAEL, Calif., May 19, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the initial purchasers of the previously announced offering of its 1.25% Senior Subord
We are only in May, but 2020 is already one of the most incredible years in stock market history.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE